Related Experiment Videos
Radiation-induced osteosarcomas in the pediatric population
Matthew Koshy1, Arnold C Paulino, Wei Y Mai
1Department of Radiology, Division of Radiation Oncology, Baylor College of Medicine, Methodist Hospital, and Texas Children's Hospital, Houston, TX 77030, USA.
Summary
Aggressively treating radiation-induced osteosarcomas (R-OS) in children improves survival. Surgery combined with chemotherapy offers the best outcomes for pediatric R-OS patients.
Area of Science:
- Pediatric Oncology
- Radiation Oncology
- Skeletal Tumors
Background:
- Radiation-induced osteosarcomas (R-OS) are aggressive pediatric tumors with historically poor prognoses.
- Understanding R-OS characteristics and survival factors is crucial for improving patient outcomes.
Purpose of the Study:
- To conduct a comprehensive literature review and analysis of pediatric R-OS cases.
- To identify key characteristics, prognostic factors, optimal treatments, and survival rates for R-OS in children.
Main Methods:
- Systematic review of English-language studies on pediatric R-OS from 1981-2004 via MEDLINE/PubMed.
- Analysis of 109 cases based on modified Cahan criteria, focusing on primary tumor type, radiation details, latency, and treatment outcomes.
Main Results:
- Common preceding cancers treated with radiation included Ewing's sarcoma and rhabdomyosarcoma.
- Median latency to R-OS was 100 months; 5-year survival rates were approximately 40-42%.
- Treatment modality significantly impacted survival: surgery plus chemotherapy yielded the highest 5-year survival (68.3%).
Conclusions:
- Treatment approach is the most critical factor influencing survival in pediatric R-OS.
- Aggressive treatment strategies, particularly combining surgery and chemotherapy, are recommended for R-OS.